Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Am J Med Genet A ; 167(7): 1560-4, 2015 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-25944702

RESUMEN

We reviewed the health records of pediatric patients with 22q11.2 deletion syndrome (22q11.2 DS) seen over a 5-year period in our 22q11.2 DS multidisciplinary clinic. We determined the prevalence of thyroid dysfunction in this population, in comparison to general population data. Statistical tests were applied to investigate trends in gender differences, thyroid disease subtype and co-morbid conditions in the patients identified with thyroid disease. Of 169 subjects (92 male, 77 female) 9.5% had overt thyroid disease; of these, 1.8% had hyperthyroidism and 7.7% had hypothyroidism; 42% of patients with subclinical or prodromal thyroid disease progressed to overt disease. Our data indicate that thyroid disease prevalence in the 22q11DS pediatric population is significantly higher than that in the general pediatric population Furthermore, over 1/3 of patients in our study population who presented with subclinical thyroid disease progressed to overt disease, requiring medical therapy. Thyroid disease screening should be incorporated into routine medical management of children with 22q11.2 DS. Guidelines for screening individuals with 22q11.2 DS are presented.


Asunto(s)
Síndrome de Deleción 22q11/epidemiología , Síndrome de Deleción 22q11/patología , Enfermedades de la Tiroides/epidemiología , Enfermedades de la Tiroides/patología , Síndrome de Deleción 22q11/complicaciones , Adolescente , Niño , Preescolar , Femenino , Humanos , Lactante , Masculino , Ontario/epidemiología , Prevalencia , Estudios Retrospectivos , Enfermedades de la Tiroides/etiología
2.
BMC Public Health ; 14: 85, 2014 Jan 28.
Artículo en Inglés | MEDLINE | ID: mdl-24467989

RESUMEN

BACKGROUND: While extensive research has been conducted on bullying and victimization in western countries, research is lacking in low- and middle-income settings. This study focused on bullying victimization in Peru. It explored the relationship between the caregiver's perception of child victimization and the child's view of selected negative experiences occurring with other children their age. Also, the study examined the association between victimization and adolescent health risk behaviors. METHODS: This study used data from 675 children participating in the Peru cohort of the Young Lives study. Children and caregivers were interviewed in 2002 when children were 8 years of age and again in 2009 when children were 15 years of age. Measures of victimization included perceptions from children and caregivers while measures of health risk behaviors included cigarette smoking, alcohol drinking, and sexual relations among adolescents. RESULTS: Caregivers identified 85 (12.6%) children bullied at ages 8 and 15, 235 (34.8%) bullied at age 8 only, 61 (9.0%) bullied at age 15 only, and 294 (43.6%) not bullied at either age. Children who were bullied at both ages compared with all other children were 1.58 (95% CI 1.00-2.50) times more likely to smoke cigarettes, 1.57 (1.04-2.38) times more likely to drink alcohol, and 2.17 (1.41-3.33) times more likely to have ever had a sexual relationship, after adjusting for gender. The caregiver's assessment of child victimization was significantly associated with child reported bullying from other children their age. Child reported victimization was significantly associated with increased risky behaviors in some cases. CONCLUSION: Long-term victimization from bullying is more strongly associated than less frequent victimization with increased risk of cigarette smoking, alcohol drinking, and sexual relations at age 15. Hence, programs focused on helping children learn how to mitigate and prevent bullying consistently over time may also help reduce risky adolescent health behaviors such as smoking, alcohol consumption, and sexual activity.


Asunto(s)
Acoso Escolar/psicología , Víctimas de Crimen/psicología , Conductas Relacionadas con la Salud , Asunción de Riesgos , Adolescente , Factores de Edad , Consumo de Bebidas Alcohólicas/epidemiología , Cuidadores/psicología , Niño , Femenino , Humanos , Masculino , Perú/epidemiología , Estudios Prospectivos , Factores de Riesgo , Conducta Sexual/estadística & datos numéricos , Fumar/epidemiología
3.
Wiley Interdiscip Rev Cogn Sci ; 12(5): e1557, 2021 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-33651922

RESUMEN

In this overview we describe literature on how speech production and speech perception change in healthy or normal aging across the adult lifespan. In the production section we review acoustic characteristics that have been investigated as potentially distinguishing younger and older adults. In the speech perception section studies concerning speaker age estimation and those investigating older listeners' perception are addressed. Our discussion focuses on major themes and other fruitful areas for future research. This article is categorized under: Linguistics > Language in Mind and Brain Linguistics > Linguistic Theory Psychology > Development and Aging.


Asunto(s)
Percepción del Habla , Habla , Anciano , Envejecimiento , Humanos , Lenguaje , Lingüística
4.
Nat Clin Pract Nephrol ; 3(3): 138-53, 2007 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17322926

RESUMEN

Uremic bleeding syndrome is a recognized consequence of renal failure and can result in clinically significant sequelae. Although the pathophysiology of the condition has yet to be fully elucidated, it is believed to be multifactorial. This article is a review of both the normal hemostatic and homeostatic mechanisms that operate within the body to prevent unnecessary bleeding, as well as an in-depth discussion of the dysfunctional components that contribute to the complications associated with uremic bleeding syndrome. As a result of the multifactorial nature of this syndrome, prevention and treatment options can include one or a combination of the following: dialysis, erythropoietin, cryoprecipitate, desmopressin, and conjugated estrogens. Here, these treatment options are compared with regard to their mechanism of action, and onset and duration of efficacy. An extensive review of the clinical trials that have evaluated each treatment is also presented. Lastly, we have created an evidence-based treatment algorithm to help guide clinicians through most clinical scenarios, and answered common questions related to the management of uremic bleeding.


Asunto(s)
Medicina Basada en la Evidencia/métodos , Hemorragia/etiología , Hemorragia/terapia , Guías de Práctica Clínica como Asunto , Uremia/complicaciones , Desamino Arginina Vasopresina/uso terapéutico , Eritropoyetina/uso terapéutico , Estrógenos Conjugados (USP)/uso terapéutico , Factor VIII/uso terapéutico , Fibrinógeno/uso terapéutico , Humanos , Diálisis Renal , Insuficiencia Renal/complicaciones , Factor de von Willebrand/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA